Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer files lawsuit against Johnson & Johnson, Janssen Biotech
10:43am, Monday, 23'rd Feb 2026
German pharmaceutical company Bayer said on Monday that it had filed a lawsuit in a New York court against Johnson & Johnson and Janssen Biotech Inc related to its Nubeqa prostate cancer drug.
Bayer Alleges J&J's Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA
10:28am, Monday, 23'rd Feb 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that it has filed suit against Johnson & Johnson (J&J) and Janssen Biotech, Inc. in the United States District Court for the Southern District of
Bayer, John Deere Further Integrate FieldView and Operations Center to Improve Customer Experience for 2026 Season
10:00am, Monday, 23'rd Feb 2026
ST. LOUIS--(BUSINESS WIRE)--Bayer and John Deere today announced a new capability that simplifies how U.S. farmers and advisors move from agronomic decisions to precise execution in the field. Beginni
Voyageur Pharmaceuticals Announces Collaboration with Bayer
08:20am, Monday, 23'rd Feb 2026
Calgary, Alberta, Canada – TheNewswire – February 23, 2026 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC Pink:VYYRF) (" Voyageur " or the " Company ") a Canadian developer of pharmaceutical-gr
Bayer proposes $7.25 billion Roundup settlement as Supreme Court case looms
01:10pm, Thursday, 19'th Feb 2026
A new $7.25 billion settlement between Bayer and a group of cancer patients could wrap up a huge wave of lawsuits against the company over allegations that it didn't warn consumers about cancer risks
First Look: Walmart beat, Meta trial, FDA eyes Moderna
07:39am, Thursday, 19'th Feb 2026
Stock News Zuckerberg testifies in youth harm case: Meta Platforms (META) CEO Mark Zuckerberg defended Instagram's design and policies in a Los Angeles trial ov
Bayer: glyphosate shortages not expected outside the US after executive order
05:39am, Thursday, 19'th Feb 2026
The U.S. President's executive order invoking the Defense Production Act to ensure U.S. supply of glyphosate underscores U.S. farmers' needs to have access to the herbicide, Bayer said on Thursday, ad
Explainer: Will Bayer's proposed $7.25 billion Roundup deal bring legal closure?
01:04am, Thursday, 19'th Feb 2026
Bayer's Monsanto unit has proposed a $7.25 billion nationwide class settlement to resolve both current and future lawsuits alleging that its Roundup weedkiller caused cancer, billing it as a long-awai
Bayer Falls 8.4% On $7.25 Billion Plan
01:00pm, Wednesday, 18'th Feb 2026
Bayer (BAYRY) sank 8.4% in European trading after unveiling a $7.25 billion proposal to settle a nationwide Roundup cancer lawsuit, and investors clearly were n
Bayer (BAYRY) Surges 6.0%: Is This an Indication of Further Gains?
10:20am, Wednesday, 18'th Feb 2026
Bayer (BAYRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Bayer shares make this surprising move after $7.25 billion Roundup settlement accord
06:02am, Wednesday, 18'th Feb 2026
Bayer stock slumped on Wednesday as the German giant set a preliminary accord to cap litigation over its weedkiller Roundup.
Bayer falls 7% after proposing $7.25 billion settlement in Roundup case; European markets open higher
03:33am, Wednesday, 18'th Feb 2026
European stocks opened higher on Wednesday as investors monitor global market developments.
Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript
Bayer Proposes New $7 Billion Plan to Settle Roundup Litigation
02:02pm, Tuesday, 17'th Feb 2026
Company says settlement would address bulk of outstanding cases; the Supreme Court has agreed to hear Bayer's appeal to neutralize cancer claims.
Bayer CEO says Roundup settlement is important addition to Supreme Court case
12:10pm, Tuesday, 17'th Feb 2026
Bayer's U.S. class settlement aimed at resolving current and future claims that Roundup weedkiller caused non‑Hodgkin lymphoma is an important addition to its Supreme Court case, Bayer CEO Bill Ande
